How much funding has Celerion (H.I.G. Capital) raised?

Celerion (H.I.G. Capital) has raised $45.0M in total funding, most recently a Private Equity round.

Who are Celerion (H.I.G. Capital)'s investors?

Celerion (H.I.G. Capital)'s investors include Thomas H. Lee Partners, H.I.G. Capital, Court Square Capital P, Bain Capital Ventures, SV Life Sciences.

When was Celerion (H.I.G. Capital) founded?

Celerion (H.I.G. Capital) was founded in 2010.

Where is Celerion (H.I.G. Capital) headquartered?

Celerion (H.I.G. Capital) is headquartered in Lincoln, Nebraska, United States.

What industry is Celerion (H.I.G. Capital) in?

Celerion (H.I.G. Capital) operates in Biotech, Healthcare.

How many employees does Celerion (H.I.G. Capital) have?

Celerion (H.I.G. Capital) has 501-1000 employees.

Celerion (H.I.G. Capital)

Acquired

Celerion: Translating Science to Medicine

Lincoln, United States · Founded 2010 · $45.0M raised

Biotech

Healthcare

Headquarters: Lincoln, Nebraska
Employees: 501–1000
Founded: 2010
Business Model: B2B

Website: celerion.com
Total Funding: $45.0M
Last Round: $45.0M Private EquityNov 2022
Rounds: 4

About

Celerion is a global clinical research organization with 50+ years of legacy history, specializing in early-phase clinical trials, bioanalytical sciences, and drug development services for pharmaceutical and biotechnology companies. Operating across North America and Europe with 650+ beds, Celerion conducts bioavailability, pharmacokinetic, and first-in-human studies through facilities in Lincoln NE, Phoenix AZ, and Belfast UK, serving clients from IND-enabling through proof-of-concept with proprietary platforms including ClinQuick and Celexus.

Summary

Celerion (H.I.G. Capital) is a Biotech company based in Lincoln, United States, founded in 2010. It has raised $45.0M in total across 4 rounds, most recently a $45.0M Private Equity round in Nov 2022. Investors include Thomas H. Lee Partners, H.I.G. Capital and Court Square Capital P.

LinkedIn X (Twitter)